Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome – new data and literature review
Abstract Background Hajdu-Cheney syndrome (HCS) (#OMIM 102500) is a rare, autosomal dominant condition that presents in early childhood. It is caused by mutations in the terminal exon of NOTCH2, which encodes the transmembrane NOTCH2 receptor. This pathway is involved in the coupled processes of bon...
Main Authors: | James F. H. Pittaway, Christopher Harrison, Yumie Rhee, Muriel Holder-Espinasse, Alan E. Fryer, Tim Cundy, William M. Drake, Melita D. Irving |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-018-0795-5 |
Similar Items
-
Correction to: Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome – new data and literature review
by: James F. H. Pittaway, et al.
Published: (2019-05-01) -
Effect of obesity on osteoporosis: A DEXA scan-based report in urban population of Belagavi
by: Saumya Agarwal, et al.
Published: (2016-01-01) -
Hajdu Cheney Syndrome
by: Shini Susan Samuel, et al.
Published: (2016-02-01) -
Hajdu–Cheney syndrome with ventricular septal defect
by: Gokhan Sargin
Published: (2013-06-01) -
Pharmacological Therapy of Osteoporosis: A Systematic Current Review of Literature
by: Vito Pavone, et al.
Published: (2017-11-01)